Venturi Wealth Management LLC increased its holdings in Chemed Co. (NYSE:CHE – Free Report) by 82.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 776 shares of the company’s stock after acquiring an additional 351 shares during the period. Venturi Wealth Management LLC’s holdings in Chemed were worth $411,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. UMB Bank n.a. raised its holdings in shares of Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after acquiring an additional 39 shares during the last quarter. Trust Co. of Vermont acquired a new stake in shares of Chemed in the 4th quarter worth about $34,000. Allworth Financial LP raised its holdings in shares of Chemed by 2,057.1% in the 4th quarter. Allworth Financial LP now owns 151 shares of the company’s stock worth $83,000 after acquiring an additional 144 shares during the last quarter. Farther Finance Advisors LLC raised its holdings in shares of Chemed by 2,314.3% in the 3rd quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock worth $203,000 after acquiring an additional 324 shares during the last quarter. Finally, KBC Group NV raised its holdings in shares of Chemed by 11.5% in the 3rd quarter. KBC Group NV now owns 378 shares of the company’s stock worth $227,000 after acquiring an additional 39 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.
Insider Activity
In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the completion of the transaction, the chief executive officer now directly owns 101,735 shares of the company’s stock, valued at $58,270,755.95. This represents a 1.93 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Spencer S. Lee sold 732 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total transaction of $421,353.84. Following the transaction, the executive vice president now directly owns 18,287 shares of the company’s stock, valued at $10,526,362.94. This represents a 3.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 3.32% of the company’s stock.
Wall Street Analysts Forecast Growth
View Our Latest Stock Report on Chemed
Chemed Stock Performance
Shares of CHE stock opened at $556.57 on Thursday. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $654.62. The company has a 50-day simple moving average of $542.70 and a two-hundred day simple moving average of $564.06. The company has a market capitalization of $8.38 billion, a price-to-earnings ratio of 28.12, a PEG ratio of 2.16 and a beta of 0.48.
Chemed Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. The ex-dividend date of this dividend is Monday, February 24th. Chemed’s payout ratio is 10.11%.
About Chemed
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Recommended Stories
- Five stocks we like better than Chemed
- How to Invest in the Best Canadian Stocks
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- The Risks of Owning Bonds
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.